Agena Bioscience signs agreement with MassARRAY

Agena Bioscience, the global manufacturer of the MassARRAY System for targeted genetic analysis has signed an exclusive distribution agreement with Alliance Global (AGBL Group) to bring the MassARRAY technology to many emerging markets across the Middle East, Africa, and Central Asia. 

Agena Bioscience signs agreement with MassARRAY

Alliance Global is a member of the AGBL group of companies, the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centers in emerging healthcare markets.

Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY® System. The system is a highly sensitive, cost-effective, mass spectrometry-based platform for high-throughput genetic analysis and is used globally in diverse clinical diagnostic and research fields such as infectious diseases, cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research. Agena received Emergency Use Authorization (EUA) for its MassARRAY SARS-CoV-2 Panel in October 2020